| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 1988 Oxford University Press
research-article |
Serum Vitamin E Level and Risk of Female Cancers
Research Institute for Social Security, PO Box 78, SF-00381, Helsinki, Finland. Departments of Biomedical Sciences and Public Health, University of Tampere Tampere, Finland and Finnish Cancer Registry, Helsinki, Finland
A sample of 15 093 women, aged 1599 and initially free from cancer, participated in the Finnish Social Insurance Institution's Mobile Clinic Health Survey in 196871. A record linkage to the Cancer Registry revealed that during a mean follow-up of eight years cancer was diagnosed in 313 women. Serum alpha-tocopherol levels were measured from stored samples (at 20 C) of the cancer patients and of 678 controls, matched for municipality and age. An inverse relation was observed between alpha-tocopherol level and risk of cancer, even if the cancers In the first two years of follow-up were excluded. Women in the lowest quintile for alpha-tocopherol levels compared to those with higher values had a 1.6-fold (95% confidence interval: 1.12.5) risk of cancer as adjusted for possible confounding effects of several other factors. A low level of alpha-tocopherol in general strongly predicted epithelial cancers while it carried an only slightly elevated risk of cancers in reproductive organs exposed to oestrogens. The results suggest that a low vitamin E intake is a risk factor for cancer in many, but not all, organs. The expression of its protective effect may depend on the primary causes, which vary between different cancers.
Revised 1 July 1987
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Gaynor One Oncologist's View of Integrative Care: Keynote Address, Comprehensive Cancer Care Conference, April 2003 Integr Cancer Ther, March 1, 2004; 3(1): 82 - 87. [PDF] |
||||
![]() |
P. E. Castle and A. R. Giuliano Chapter 4: Genital Tract Infections, Cervical Inflammation, and Antioxidant Nutrients--Assessing Their Roles as Human Papillomavirus Cofactors J Natl Cancer Inst Monographs, June 1, 2003; 2003(31): 29 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sato, K. J. Helzlsouer, A. J. Alberg, S. C. Hoffman, E. P. Norkus, and G. W. Comstock Prospective Study of Carotenoids, Tocopherols, and Retinoid Concentrations and the Risk of Breast Cancer Cancer Epidemiol. Biomarkers Prev., May 1, 2002; 11(5): 451 - 457. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kaul, S. Devaraj, and I. Jialal {{alpha}}-Tocopherol and Atherosclerosis Experimental Biology and Medicine, January 1, 2001; 226(1): 5 - 12. [Abstract] [Full Text] |
||||
![]() |
M. Iqbal, H. Rezazadeh, S. Ansar, and M. Athar {alpha}-Tocopherol (vitamin-E) ameliorates ferric nitrilotriacetate (Fe-NTA)-dependent renal proliferative response and toxicity: diminution of oxidative stress Human and Experimental Toxicology, March 1, 1998; 17(3): 163 - 171. [Abstract] [PDF] |
||||




